Drug & intervention

sunvozertinib

RxCUI 2719226

Clinical trials11
Recruiting6
Related conditions6
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

11 shown
A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical SurgeryNCT07182682 · 2025-12-01
RECRUITING
Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)NCT07079475 · 2025-07-30
RECRUITING
A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN1)NCT06905197 · 2025-05-13
RECRUITING
Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLCNCT06864624 · 2025-02-18
RECRUITING
Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.NCT06563999 · 2024-11-01
RECRUITING
Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure：Phase I/IINCT06195189 · 2024-02-29
RECRUITING
Real-world Study of Sunvozertinib Treatment in Advanced EGFR-Mutant NSCLC After EGFR-TKI Treatment FailureNCT06786208 · 2025-02-01
NOT_YET_RECRUITING
Neoadjuvant Sunvozertinib in Stage II-IIIB Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutation.NCT07274761 · 2024-10-17
ACTIVE_NOT_RECRUITING
A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)NCT05668988 · 2022-12-13
ACTIVE_NOT_RECRUITING
Sunvozertinib (DZD9008) in Pretreated Lung Cancer Patients with EGFR Exon20 Insertion Mutation (WU-KONG6)NCT05712902 · 2021-07-19
ACTIVE_NOT_RECRUITING
Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)NCT03974022 · 2019-07-09
ACTIVE_NOT_RECRUITING

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.